Selecta Biosciences, Inc. (SELB) Q1 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the Selecta Biosciences first quarter 2022 financial results and corporate update conference call. Currently, all participants are in a listen-only mode. This call is being webcast live on the investors and media section of Selecta's website at www.selectabio.com, and it is being recorded. For opening remarks, I would like to introduce Kevin Tan, Chief Financial Officer of Selecta. Please go ahead. Thank you and good morning. Welcome to our first quarter 2022 financial results and corporate update conference call. The press release reporting our financial results is available in the investors and media section of Selective's website, worldwidewebselectivebio.com. And our quarterly report on form 10Q for the quarter ended March 31st, 2022, which will be filed today with the Securities and Exchange Commission or SEC. Joining me today are Carson Bruin, President and Chief Executive Officer, Peter Traber, Chief Medical Officer, and Kate Kishimoto, Chief Scientific Officer. During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the potential safety, efficacy, and regulatory and clinical progress of our product candidates, financial projections, and our future expectations plans, partnerships, and prospects. These statements are subject to various risks that are described in the filings made with the SEC, including our quarterly report on Form 10Q. Your caution is not to place undue reliance on these forward-looking statements, which speak only as of today, May 5, 2022, and select a disclaims any obligation to update such statements, even if management's views change. I would now like to turn the call over to Carson. Carson? Good morning. I appreciate everyone taking the time t...